Market revenue in 2023 | USD 13,368.1 million |
Market revenue in 2030 | USD 5,065.7 million |
Growth rate | -12.9% (CAGR from 2023 to 2030) |
Largest segment | Hospitals |
Fastest growing segment | Home Care |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care |
Key market players worldwide | Becton Dickinson & Co, BioMerieux SA, Bio-Rad Laboratories Inc, Abbott Laboratories, Agilent Technologies Inc, Danaher Corp, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Roche Holding AG, Siemens Healthineers AG ADR, Sysmex Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular diagnostics market will help companies and investors design strategic landscapes.
Hospitals was the largest segment with a revenue share of 46.99% in 2023. Horizon Databook has segmented the Europe molecular diagnostics market based on hospitals, outpatient facilities, home care covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing prevalence of genetic and cardiovascular disorders and growing investments in proteomics & genomic research initiatives are expected to drive the market. However, the current European economic crisis and uneven reimbursement policies are market restraints. In 2017, a new regulation was issued regarding IVD & medical devices in European countries, updated in 2022.
The new regulation is expected to offer a more sustainable & robust framework for compliance with molecular diagnostic devices. Europe is the second-largest market for molecular diagnostics in terms of revenue share, which can be attributed to the presence of developed economies such as Germany, Turkey, the UK, France, and Italy.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe molecular diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account